Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in SGMT — Sagimet Biosciences Inc.

CIK 1603466 STAMFORD, CT
Back to SGMT Full portfolio

Position in SGMT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$980,021
-$60,892 QoQ
Shares Held
187,564
+6.7% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Derivatives in SGMT

reported options exposure · as of Dec 31, 2024
CallValue
$108,450
CallShares
24,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in SGMT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $980,021 187,564
2025-12-31 $1,040,913 175,830
2025-03-31 $5,721,766 1,755,143
2024-12-31 $10,424,574 2,316,572
2024-12-31 $108,450 24,100
2024-09-30 $6,631,180 2,393,928
2024-09-30 $205,534 74,200
2024-06-30 $8,092,027 2,366,090
2024-03-31 $14,453,969 2,666,784